Hematocrit corrected glucose measurements using phase angles and impedance for electrochemical test strip

US9322800B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9322800-B2
Application numberUS-201213261834-A
CountryUS
Kind codeB2
Filing dateAug 31, 2012
Priority dateSep 2, 2011
Publication dateApr 26, 2016
Grant dateApr 26, 2016

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Two techniques of determining hematocrit using impedance and phase angle to determine hematocrit are shown and described for correcting an analyte concentration.

First claim

Opening claim text (preview).

What is claimed is: 1. A method to determine analyte concentration in a blood sample, the method comprising: depositing a blood sample in a test chamber of a test strip having at least first and second electrodes in contact with a reagent and third and fourth electrodes not in contact with the reagent; driving a non-oscillating signal to the at least first and second electrodes to cause a reaction with the glucose in the blood sample and the reagent; measuring a current output of the reaction to establish a preliminary analyte concentration; applying a first oscillating input signal at a first frequency to third and fourth electrodes, the first frequency comprising any frequency in a range of about 20,000 Hertz to about 60,000 Hertz; determining a first estimated hematocrit based on an impedance from output signals of the third and fourth electrodes; applying a second oscillating input signal at a second frequency higher than the first frequency to the third and fourth electrodes, the second frequency comprising any frequency in a range from about 100,000 Hertz to about 1,000,000 Hertz; ascertaining a second estimated hematocrit based on a phase angle of output signals from the third and fourth electrodes; estimating a hematocrit of the blood sample based on the first and second estimated hematocrits; and deriving a final analyte concentration based on the preliminary analyte concentration and the hematocrit from the estimating step. 2. The method of claim 1 , in which the second frequency is one order of magnitude higher than the first frequency. 3. The method of claim 2 , in which the first frequency comprises about 25,000 Hertz and the second frequency comprises about 250,000 Hertz. 4. The method of claim 1 , in which the determining comprises utilizing an equation to determine the first estimated hematocrit HCT est1 : HCT est ⁢ ⁢ 1 =  Z  - c ⁢ ⁢ 1 m ⁢ ⁢ 1 where |Z| comprises the measured modulus of impedance of the blood sample at the first frequency, c1 and m1 are calibration coefficients. 5. The method of claim 4 , in which the measuring of a current output for the preliminary analyte concentration is performed prior to the estimating of the hematocrit. 6. The method of claim 4 , in which the deriving comprises calculating the final analyte concentration G F from: G F = ( I E 1 - k ( HCT final_est - h 0 ) - c 4 m 4 . Where I E comprises a magnitude of the measured end current HCT final _ est comprises the hematocrit, h 0 comprises nominal hematocrit, and k, m4 and c 4 comprise parameters from regressions data. 7. The method of claim 1 , in which the ascertaining comprises utilizing an equation to determine the second estimated hematocrit HCT est2 of the form: HCT est ⁢ ⁢ 2 = ( Φ - c ⁢ ⁢ 2 ) m ⁢ ⁢ 2 where Φ comprises a measured phase angle of the blood sample at one or more second frequencies higher than the first frequency; c2 and m2 comprise respective calibration coefficients. 8. The method of claim 1 , in which the ascertaining comprises utilizing an equation to determine the second estimated hematocrit HCT est2 of the form: HCT est ⁢ ⁢ 2 = ( Φ f ⁢ ⁢ 2 - Φ f ⁢ ⁢ 1 - c ⁢ ⁢ 3 ) m ⁢ ⁢ 3

Assignees

Inventors

Classifications

  • G01N27/416Primary

    Systems (G01N27/27 takes precedence) · CPC title

  • Corrective measures, e.g. error detection, compensation for temperature or hematocrit, calibration (coding of calibration information G01N33/48771) · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9322800B2 cover?
Two techniques of determining hematocrit using impedance and phase angle to determine hematocrit are shown and described for correcting an analyte concentration.
Who is the assignee on this patent?
Mccoll David, Farmahan Mandip, Smith Antony, and 1 more
What technology area does this patent fall under?
Primary CPC classification G01N27/416. Mapped technology areas include Physics.
When was this patent published?
Publication date Tue Apr 26 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).